相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Contrasting Effects of Ferric and Ferrous Ions on Oligomerization and Droplet Formation of Tau: Implications in Tauopathies and Neurodegeneration
Sandipan Mukherjee et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation
Carolina Alquezar et al.
FRONTIERS IN NEUROLOGY (2021)
C1 Inhibits Liquid-Liquid Phase Separation and Oligomerization of Tau and Protects Neuroblastoma Cells against Toxic Tau Oligomers
Arpan Pradhan et al.
ACS CHEMICAL NEUROSCIENCE (2021)
The Acetyl Mimicking Mutation, K274Q in Tau, Enhances the Metal Binding Affinity of Tau and Reduces the Ability of Tau to Protect DNA
Jitendra Subhash Rane et al.
ACS CHEMICAL NEUROSCIENCE (2020)
The antidepressant drug; trazodone inhibits Tau amyloidogenesis: Prospects for prophylaxis and treatment of AD
Vali Akbari et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Pyridine-2,3-dicarboxylate, quinolinic acid, induces 1N4R Tau amyloid aggregation in vitro: Another evidence for the detrimental effect of the inescapable endogenous neurotoxin
Sajjad Esmaeili et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Targeting tau: Clinical trials and novel therapeutic approaches
Lawren VandeVrede et al.
NEUROSCIENCE LETTERS (2020)
Much More Than a Cytoskeletal Protein: Physiological and Pathological Functions of the Non-microtubule Binding Region of Tau
Roland Brandt et al.
FRONTIERS IN NEUROLOGY (2020)
An acetylation mimicking mutation, K274Q, in tau imparts neurotoxicity by enhancing tau aggregation and inhibiting tubulin polymerization
Jitendra S. Rane et al.
BIOCHEMICAL JOURNAL (2019)
Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies
Anuradha Venkatramani et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects
Pascale Barbier et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Molecular Pathogenesis of the Tauopathies
Jurgen Gotz et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14 (2019)
Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides
Guru KrishnaKumar Viswanathan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
Gordon K. Wilcock et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Tau protein liquid-liquid phase separation can initiate tau aggregation
Susanne Wegmann et al.
EMBO JOURNAL (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Shikonin Protects PC12 Cells Against β-amyloid Peptide-Induced Cell Injury Through Antioxidant and Antiapoptotic Activities
Yuna Tong et al.
SCIENTIFIC REPORTS (2018)
Effective suppression of the modified PHF6 peptide/1N4R Tau amyloid aggregation by intact curcumin, not its degradation products: Another evidence for the pigment as preventive/therapeutic functional food
Nooshin Bijari et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases
Ashley N. Nilson et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules
Jennifer N. Rauch et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro
Jitendra Subhash Rane et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Effect of Shikonin on Spinal Cord Injury in Rats Via Regulation of HMGB1/TLR4/NF-κB Signaling Pathway
Yihui Bi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Roles of tau protein in health and disease
Tong Guo et al.
ACTA NEUROPATHOLOGICA (2017)
Tau and neurodegenerative disease: the story so far
Khalid Iqbal et al.
NATURE REVIEWS NEUROLOGY (2016)
Tau in physiology and pathology
Yipeng Wang et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Novel Combretastatin-2-aminoimidazole Analogues as Potent Tubulin Assembly Inhibitors: Exploration of Unique Pharmacophoric Impact of Bridging Skeleton and Aryl Moiety
Vikas Chaudhary et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Serge Gauthier et al.
LANCET (2016)
Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies
Marcus Pickhardt et al.
CURRENT ALZHEIMER RESEARCH (2015)
Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo
Marie Violet et al.
NEUROBIOLOGY OF DISEASE (2015)
Neuropathology of tauopathies: principles and practice
G. G. Kovacs
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
A mechanistic model of tau amyloid aggregation based on direct observation of oligomers
Sarah L. Shammas et al.
NATURE COMMUNICATIONS (2015)
Structure and Mechanism of Action of Tau Aggregation Inhibitors
Katryna Cisek et al.
CURRENT ALZHEIMER RESEARCH (2014)
Evaluation of radical scavenging properties of shikonin
Lucia S. Yoshida et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2014)
Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein
Simon Dujardin et al.
PLOS ONE (2014)
A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions
Marie Violet et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Formation and propagation of tau oligomeric seeds
Julia E. Gerson et al.
FRONTIERS IN NEUROLOGY (2013)
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
Cristian A. Lasagna-Reeves et al.
FASEB JOURNAL (2012)
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
Sudad Saman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity
Zhenhua Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Tau protein and tau aggregation inhibitors
Bruno Bulic et al.
NEUROPHARMACOLOGY (2010)
Development of Tau Aggregation Inhibitors for Alzheimer's Disease
Bruno Bulic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Shikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-κB: neuroprotective implications
Kyong Nyon Nam et al.
NEUROPHARMACOLOGY (2008)
Differential regulation of dynein and kinesin motor proteins by tau
Ram Dixit et al.
SCIENCE (2008)
WSXM: A software for scanning probe microscopy and a tool for nanotechnology
I. Horcas et al.
REVIEW OF SCIENTIFIC INSTRUMENTS (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Global hairpin folding of tau in solution
S Jeganathan et al.
BIOCHEMISTRY (2006)
Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins
S Taniguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells
M Pickhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease
D Panda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress
K Stamer et al.
JOURNAL OF CELL BIOLOGY (2002)